The HPI

The institute's mission statement: „The HPI investigates the biology of human pathogenic viruses. It is our aim to unravel the molecular mechanisms that control viral life cycles and virus induced pathogenesis. This research will provide novel targets and therapeutic approaches for established and emerging viral disease.Learn more about the HPI.

Research Units

The Heinrich Pette Institute's research teams currently consist of four reserach units, three reserach groups and three independent junior research groups.

For more information visit the RESEARCH Teams.

European Congress of Virology

Oktober 19-22, 2016 at the Congress Center Hamburg

More Infos HERE

Leibniz Year 2016

Leibniz Year 2016 -  the 370. birthday and 300. anniversary of death of the polymath Gottfried Wilhelm Leibniz: Reason for a Theme Year by the Leibniz Association.

www.bestewelten.de

News

April 5, 2016: Brec1 Recombinase as cover image on the current "Nature Biotechnology" issue

Tuesday, 05. April 2016

April 5, 2016: Image shows designer recombinase Brec1, developed at the HPI and the TU-Dresden

April 4, 2016: HCV strategy to avoide innate immune response

Monday, 04. April 2016

April 4, 2016: Sequence variations within HCV can modulate NK cell function

Press

Recombinase Brec1 trend-setting for future HIV Therapy

Monday, 22. February 2016

Heinrich Pette Institute, Leibniz Institute for Experimental Virology: Approach demonstrated to work directly on HIV-patient material

Hamburg's Science Management in Geneva: International health care policy in critical times

Monday, 15. February 2016

HPI's Administrative Director Dr. Nicole Elleuche residences at the German Permanent Missions with the focus on 'health/WHO'

Seminars

Human Papillomaviruses: From Infectious Entry to Malignancy

Thursday, 12. May 2016 - 15:15

Prof. Lawrence Banks

Tumour Virology, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy

im Ferdinand-Bergen-Auditorium des HPI

Wiring the brain with guidance cues and receptors

Thursday, 26. May 2016 - 10:52

Dr. Rob Meijers

European Molecular Biology Laboratory (EMBL), c/o DESY, Hamburg

im Ferdinand-Bergen-Auditorium des HPI